Global Checkpoint Inhibitors Market to Surpass USD 98.6 Billion by 2031, Fueled by Growth in Cancer Immunotherapy and Adoption of Precision Medicine
[New York, 3 July 2025] – Clearview Market Insights (CVMI) predicts that the global checkpoint inhibitors market will increase from USD 41.9 billion in 2024 to USD 98.6 billion by 2031, with a CAGR of 12.9%. Rising cancer rates, more FDA approvals, and growth in biomarker-driven precision medicine are fueling record-high demand. Checkpoint inhibitors are transforming the oncology...
0 Комментарии 0 Поделились 3 Просмотры 0 предпросмотр
Спонсоры